Back to Search
Start Over
Antenatal magnesium sulphate for preventing cerebral palsy: An economic evaluation of the impact of a quality improvement program.
- Source :
-
The Australian & New Zealand journal of obstetrics & gynaecology [Aust N Z J Obstet Gynaecol] 2022 Feb; Vol. 62 (1), pp. 168-171. Date of Electronic Publication: 2021 Nov 29. - Publication Year :
- 2022
-
Abstract
- Previous work demonstrated that implementing a quality improvement (QI) program improves the uptake of guideline-recommended antenatal magnesium sulphate, a critical intervention known to reduce cerebral palsy risk. Here we estimate potential cost savings attributable to the improved uptake. By expanding coverage from 63 to 83% of eligible women, we estimated that five children potentially would not have received a diagnosis of cerebral palsy, a potential cost saving of $AU4.8 million in lifetime healthcare costs. Our findings strengthen the case for embedding QI approaches in perinatal care to reduce the incidence of cerebral palsy.<br /> (© 2021 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.)
Details
- Language :
- English
- ISSN :
- 1479-828X
- Volume :
- 62
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- The Australian & New Zealand journal of obstetrics & gynaecology
- Publication Type :
- Academic Journal
- Accession number :
- 34843629
- Full Text :
- https://doi.org/10.1111/ajo.13459